Evidence map›Paper›PMID 34512628›Full record

ArticleFrontiers in immunology2021

Impaired B Cell Apoptosis Results in Autoimmunity That Is Alleviated by Ablation of Btk.

Jacqueline A Wright, Cassandra Bazile, Emily S Clark, Gianluca Carlesso, Justin Boucher, Eden Kleiman, Tamer Mahmoud, Lily I Cheng, Darlah M López-Rodríguez, Anne B Satterthwaite and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Distributed Clonal Deletion Prevents Autoimmune Disease Progression.bioRxiv : the preprint server for biology · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. The ion transporter NaScience advances · 2023
    Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Jacqueline A WrightDepartment of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL, United States.
Cassandra BazileDepartment of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL, United States.
Emily S ClarkDepartment of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL, United States.
Gianluca CarlessoEarly Oncology Discovery, Early Oncology R&D, AstraZeneca, Gaithersburg, MD, United States.
Justin BoucherDepartment of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL, United States.
Eden KleimanDepartment of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL, United States.
Tamer MahmoudEarly Oncology Discovery, Early Oncology R&D, AstraZeneca, Gaithersburg, MD, United States.
Lily I ChengOncology Safety/Pathology, Clinical Pharmacology and Safety Sciences, AstraZeneca, Gaithersburg, MD, United States.
Darlah M López-RodríguezDepartment of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL, United States.
Anne B SatterthwaiteDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Norman H AltmanDepartment of Pathology, Miller School of Medicine, University of Miami, Miami, FL, United States.
Eric L GreidingerDepartment of Medicine, Miller School of Medicine, University of Miami, Miami, FL, United States.
Wasif N KhanDepartment of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL, United States.
University of Miami · USAstraZeneca (United States) · USThe University of Texas Southwestern Medical Center · US

Funding

BTK SIGNALING IN B CELL SURVIVAL BY BAFF-RR21AI088511 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI KHAN, WASIF N. · 2010 to 2011
$419k
NIAID NIH HHS R21 AI088511
6 · The paper itself

Abstract

While apoptosis plays a role in B-cell self-tolerance, its significance in preventing autoimmunity remains unclear. Here, we report that dysregulated B cell apoptosis leads to delayed onset autoimmune phenotype in mice. Our longitudinal studies revealed that mice with B cell-specific deletion of pro-apoptotic Bim (

Indexed as

Agammaglobulinaemia Tyrosine KinaseAnimalsAntibody SpecificityApoptosisAutoantibodiesAutoimmune DiseasesAutoimmunityBcl-2-Like Protein 11B-LymphocytesCell DivisionCells, CulturedHypergammaglobulinemiaImmune ToleranceLupus Erythematosus, SystemicMiceMice, Inbred C57BLAgammaglobulinaemia Tyrosine KinaseAutoantibodiesBcl2l11 protein, mouseBcl-2-Like Protein 11Btk protein, mouseReceptors, AntigenapoptosisautoantibodiesautoimmunityB cell toleranceBcl-2-like 11 (Bim)Bruton’s tyrosine kinase (Bkt)Sjogren’s syndromesystemic lupus - erythematosus

Identifiers

PMID34512628
PMCPMC8427801
OpenAlexW3198761142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.